Chemoinformaics analysis of 3-O-methyl-isosecotanapartholide
Molecular Weight | 292.331 | nRot | 5 |
Heavy Atom Molecular Weight | 272.171 | nRig | 14 |
Exact Molecular Weight | 292.131 | nRing | 2 |
Solubility: LogS | -2.286 | nHRing | 1 |
Solubility: LogP | 0.435 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 44.0659 |
nHD | 0 | BPOL | 26.1401 |
QED | 0.57 |
Synth | 4.276 |
Natural Product Likeliness | 2.498 |
NR-PPAR-gamma | 0.965 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.046 |
Pgp-sub | 0.001 |
HIA | 0.174 |
CACO-2 | -4.619 |
MDCK | 0.0000184 |
BBB | 0.887 |
PPB | 0.698699 |
VDSS | 0.483 |
FU | 0.300816 |
CYP1A2-inh | 0.044 |
CYP1A2-sub | 0.257 |
CYP2c19-inh | 0.123 |
CYP2c19-sub | 0.815 |
CYP2c9-inh | 0.084 |
CYP2c9-sub | 0.068 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.348 |
CYP3a4-inh | 0.03 |
CYP3a4-sub | 0.352 |
CL | 7.994 |
T12 | 0.421 |
hERG | 0.01 |
Ames | 0.081 |
ROA | 0.477 |
SkinSen | 0.552 |
Carcinogencity | 0.813 |
EI | 0.109 |
Respiratory | 0.919 |
NR-Aromatase | 0.839 |
Antiviral | Yes |
Prediction | 0.810793 |